Literature DB >> 1701127

Modulation of glucose-induced insulin secretion from a rat clonal beta-cell line.

S A Clark1, B L Burnham, W L Chick.   

Abstract

The present studies demonstrate that the beta-cell line RINr1046-38 (RIN-38) retains the capability to secrete insulin in response to glucose. The maximal effect of glucose was a 5- to 9-fold stimulation of insulin secretion from RIN-38 cells. This glucose-induced insulin secretion was maximal at 0.6 mM and was modulated by other secretagogues. Potassium concentrations of 10 mM, adenylate cyclase activators (glucagon-like peptide-1 and forskolin), and a phosphodiesterase inhibitor (isobutylmethylxanthine) potentiated glucose-induced insulin secretion, but had little or no effect on insulin secretion in the absence of glucose. Potassium concentrations of 20 mM or more, glibenclamide, and carbachol (Cch) stimulated insulin secretion 8- to 12-fold in the absence of glucose, while only Cch potentiated the effect of glucose on insulin secretion. Amino acids (alanine, arginine, leucine, and ketoisocaproate) also stimulated insulin secretion. The alpha 2-adrenergic agonist clonidine (1 microM), low extracellular calcium (less than or equal to 0.5 mM), and extended culture of RIN-38 cells at low glucose concentrations (0.33 mM) inhibited the stimulatory effect of glucose on insulin secretion. Insulin secretion was retained in RIN-38 cells for up to 98 passages. However, extended passage was associated with a decline in cellular insulin content (83% decline over 89 passages). In addition, high passage cells lost the ability to secrete insulin in response to glucose, but continued to respond to other secretagogues (K+, alanine, and carbachol). In fact, in the absence of glucose the effect of Cch on insulin secretion was well maintained in high passage cells (8- and 9.9-fold increase in insulin secretion, passages 9 and 70, respectively). Thus, low passage RIN-38 cells secrete insulin in response to glucose and other insulin secretagogues. High passage cells do not respond to glucose, but continue to respond to other secretagogues. Based on these results we propose that high and low passage RIN-38 cells provide a model for examining molecular mechanisms of glucose-induced insulin secretion. In addition, these findings emphasize that passage information is essential for interpretation of secretion studies with RIN cell lines.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1701127     DOI: 10.1210/endo-127-6-2779

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  19 in total

1.  Computed tomography-based spectral imaging for fluorescence microscopy.

Authors:  B K Ford; C E Volin; S M Murphy; R M Lynch; M R Descour
Journal:  Biophys J       Date:  2001-02       Impact factor: 4.033

2.  DBI mRNA is expressed in endocrine pancreas and its post-translational product DBI(33-50) inhibits insulin release.

Authors:  P Borboni; R Magnaterra; O Porzio; A Fusco; G Sesti; A Bertoli; R Lauro; L N Marlier
Journal:  Endocrine       Date:  1995-04       Impact factor: 3.633

Review 3.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

Review 4.  [Insulin producing cells as therapy in diabetes mellitus].

Authors:  W J Schnedl; H E Hohmeier; C B Newgard
Journal:  Naturwissenschaften       Date:  1996-01

5.  Effect of biotin on glucokinase activity, mRNA expression and insulin release in cultured beta-cells.

Authors:  P Borboni; R Magnaterra; R A Rabini; R Staffolani; O Porzio; G Sesti; A Fusco; L Mazzanti; R Lauro; L N Marlier
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

6.  Stable expression of manganese superoxide dismutase (MnSOD) in insulinoma cells prevents IL-1beta- induced cytotoxicity and reduces nitric oxide production.

Authors:  H E Hohmeier; A Thigpen; V V Tran; R Davis; C B Newgard
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

7.  The level of menadione redox-cycling in pancreatic β-cells is proportional to the glucose concentration: role of NADH and consequences for insulin secretion.

Authors:  Emma Heart; Meridith Palo; Trayce Womack; Peter J S Smith; Joshua P Gray
Journal:  Toxicol Appl Pharmacol       Date:  2011-11-15       Impact factor: 4.219

8.  Inhibition of the high-affinity glucose transporter GLUT 1 affects the sensitivity to glucose in a hamster-derived pancreatic beta cell line (HIT).

Authors:  A M Rabuazzo; M Buscema; C Vinci; V Caltabiano; M Anello; R Vigneri; F Purrello
Journal:  Diabetologia       Date:  1993-11       Impact factor: 10.122

9.  Islet cell autoantigen 69 kD (ICA69). Molecular cloning and characterization of a novel diabetes-associated autoantigen.

Authors:  M Pietropaolo; L Castaño; S Babu; R Buelow; Y L Kuo; S Martin; A Martin; A C Powers; M Prochazka; J Naggert
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

10.  Pancreatic beta cell line MIN6 exhibits characteristics of glucose metabolism and glucose-stimulated insulin secretion similar to those of normal islets.

Authors:  H Ishihara; T Asano; K Tsukuda; H Katagiri; K Inukai; M Anai; M Kikuchi; Y Yazaki; J I Miyazaki; Y Oka
Journal:  Diabetologia       Date:  1993-11       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.